Renge Bu

433 total citations
12 papers, 292 citations indexed

About

Renge Bu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Renge Bu has authored 12 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Renge Bu's work include Epigenetics and DNA Methylation (4 papers), Renal and related cancers (3 papers) and Cancer-related molecular mechanisms research (3 papers). Renge Bu is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Renal and related cancers (3 papers) and Cancer-related molecular mechanisms research (3 papers). Renge Bu collaborates with scholars based in China and United States. Renge Bu's co-authors include Yongsheng Song, Xiang Fei, Bo Yin, Wenyan Zhao, Bin Wu, Ming Li, Bin Wu, Ming Sun, Zhaofu Chen and Ying Wang and has published in prestigious journals such as Journal of Cellular Physiology, Oncotarget and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Renge Bu

12 papers receiving 286 citations

Peers

Renge Bu
Gabriela Mendoza United States
Renge Bu
Citations per year, relative to Renge Bu Renge Bu (= 1×) peers Juchao Ren

Countries citing papers authored by Renge Bu

Since Specialization
Citations

This map shows the geographic impact of Renge Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renge Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renge Bu more than expected).

Fields of papers citing papers by Renge Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renge Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renge Bu. The network helps show where Renge Bu may publish in the future.

Co-authorship network of co-authors of Renge Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Renge Bu. A scholar is included among the top collaborators of Renge Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renge Bu. Renge Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Bu, Renge, et al.. (2020). Expression of Tight Junction Proteins Is Altered in Bladder Cancer. Analytical Cellular Pathology. 2020. 1–8. 4 indexed citations
2.
Li, Ming & Renge Bu. (2020). Biological Support to Obesity Paradox in Renal Cell Carcinoma: A Review. Urologia Internationalis. 104(11-12). 837–848. 11 indexed citations
3.
Cheng, Liang, Hongxian Zhang, Lulin Ma, et al.. (2020). Laparoscopic and Robotic-Assisted Partial Nephrectomy: An Overview of Hot Issues. Urologia Internationalis. 104(9-10). 669–677. 13 indexed citations
4.
Sun, Ming, et al.. (2020). Lentinan Inhibits Tumor Progression by Immunomodulation in a Mouse Model of Bladder Cancer. Integrative Cancer Therapies. 19. 1872165255–1872165255. 26 indexed citations
5.
Xu, Xuewen, Kai You, & Renge Bu. (2019). Proximal Tubular Development Is Impaired with Downregulation of MAPK/ERK Signaling, HIF-1α, and Catalase by Hyperoxia Exposure in Neonatal Rats. Oxidative Medicine and Cellular Longevity. 2019. 1–16. 8 indexed citations
6.
Sun, Ming, Wenyan Zhao, Zhaofu Chen, et al.. (2018). Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR‐145‐5p. Journal of Cellular Physiology. 234(4). 4812–4824. 55 indexed citations
7.
Li, Ming, Ying Wang, Liang Cheng, et al.. (2017). Long non-coding RNAs in renal cell carcinoma: A systematic review and clinical implications. Oncotarget. 8(29). 48424–48435. 34 indexed citations
8.
Li, Ming, Ying Wang, Yongsheng Song, et al.. (2015). MicroRNAs in renal cell carcinoma: A systematic review of clinical implications (Review). Oncology Reports. 33(4). 1571–1578. 63 indexed citations
9.
Li, Ming, Ying Wang, Yongsheng Song, et al.. (2014). Expression profiling and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in sporadic human renal cell carcinoma.. PubMed. 7(11). 7597–609. 17 indexed citations
10.
Li, Ming, Ying Wang, Yongsheng Song, et al.. (2014). Aberrant DNA methyltransferase 1 expression in clear cell renal cell carcinoma development and progression.. PubMed. 26(4). 371–81. 18 indexed citations
11.
Wang, Xiaobin, Huihan Wang, Renge Bu, et al.. (2012). Methylation and aberrant expression of the Wnt antagonist secreted Frizzled-related protein 1 in bladder cancer. Oncology Letters. 4(2). 334–338. 16 indexed citations
12.
Cai, Dawei, Xuefeng Liu, Renge Bu, et al.. (2010). Association of polymorphisms in folate metabolic genes and prostate cancer risk: a case-control study in a Chinese population. Journal of Genetics. 89(2). 263–267. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026